Overall payments for top drugs to dip slightly; more individual prices go up
There's good news and bad news for your drug billing as 2010 kicks off. Aggregate payments for the top 50 drugs billed to Medicare are expected to dip by 1.1%, although more individual drug codes will see boosts than cuts in the first quarter of 2010 under Medicare's average sales price (ASP) +6% payment system.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.